General Info
Brian Kinman is the Chairman & CEO of St. Louis Arch Angels. He focuses on funding early-stage businesses in the St. Louis region, with investments exceeding $100 million in over 100 companies since 2005. Recent investments include IDEATE Medical, CoverCress, and Aptimmune Biologics. Brian Kinman’s professional career spans over 38 years at PricewaterhouseCoopers. His investment check size ranges, with a notable investment of $375K in PolicyEngage. Collaboration styles emphasize regional improvement and financial success.
Location: Saint Louis, Missouri, United States
Country: United States of America
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: I found a February 19, 2025 article stating Arch Angels (led by Brian Kinman) provided funding that supported IDEATE Medical achieving FDA 510(k) clearance at the end of June 2024. That indicates investment activity within the last 6 months from the reference date, with IDEATE Medical as the startup invested. Based on the date difference, classify as very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Brian Kinman
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI